42077

SAFC

Sodium cyanoborohydride

PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.

Synonym(s):
Sodium cyanotrihydridoborate
Linear Formula:
NaBH3CN
CAS Number:
Molecular Weight:
62.84
Beilstein/REAXYS Number:
4152656
EC Number:
MDL number:
PubChem Substance ID:
NACRES:
NA.21
Pricing and availability is not currently available.

Quality Level

biological source

synthetic

Agency/Method

non-compendial

product line

PharmaGrade

assay

≥97 wt. % (redox titration)

form

powder

shelf life

limited shelf life, expiry date on the label

reaction suitability

reagent type: reductant

impurities

≤1000 ppm residual solvent (tetrahydrofuran)
≤3000 ppm residual solvent (toluene)

mp

>242 °C (dec.) (lit.)

solubility

H2O: 100 mg/mL, clear to faintly turbid, colorless

anion traces

(may contain traces of cyanide and borohydride)

cation traces

Ag: ≤2.5 mg/kg
Cd: ≤2.5 mg/kg
Cr: ≤2.5 mg/kg
Cu: ≤10 mg/kg
Fe: ≤10 mg/kg
Mo: ≤2.5 mg/L
Ni: ≤2.5 mg/kg

suitability

suitable for manufacturing use

SMILES string

[Na+].[BH3-]C#N

InChI

1S/CH3BN.Na/c2-1-3;/h2H3;/q-1;+1

InChI key

CVDUGUOQTVTBJH-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

PharmaGrade products are manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production. For more information on the PharmaGrade Program, visit sigma-aldrich.com/safc-pharmagrade.

Signal Word

Danger

Supp Hazards

EUH032

RIDADR

UN 3179 6.1(4.1) / PGII

WGK Germany

WGK 3

Flash Point(F)

158.0 °F

Flash Point(C)

70 °C

Koen van der Maaden et al.
Langmuir : the ACS journal of surfaces and colloids, 31(31), 8654-8660 (2015-07-07)
The aim of this work was to coat pH-sensitive microneedle arrays with inactivated polio vaccine (IPV) particles and N-trimethyl chitosan chloride (TMC) via electrostatic interactions, and assess the immunogenicity of the vaccine after topical application of the coated microneedles in...
Lowell J Brady et al.
mAbs, 7(3), 562-570 (2015-04-22)
Accurate measurement and functional characterization of antibody Fc domain N-linked glycans is critical to successful biosimilar development. Here, we describe the application of methods to accurately quantify and characterize the N-linked glycans of 2 IgG1 biosimilars with effector function activity...
Hwiwon Lee et al.
ACS nano, 8(5), 4790-4798 (2014-04-16)
Rheumatoid arthritis (RA) is a chronic inflammatory immune disease causing the inflammation of synovial membrane and the articular cartilage destruction. In this work, hyaluronate-gold nanoparticle/Tocilizumab (HA-AuNP/TCZ) complex was prepared for the treatment of RA. AuNP was used as a drug...
Ruby Bansal et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 87(3), 461-471 (2014-05-16)
Intracellular nature and diversified locations of infectious and parasitic diseases such as leishmaniasis, trypanosomiasis, tuberculosis and hepatitis B and C pose a significant global burden and challenge to the scientists working in the area of drug discovery and drug delivery....
Jana Kucerova et al.
Materials science & engineering. C, Materials for biological applications, 40, 308-315 (2014-05-27)
In this study, magnetic poly(glycidyl methacrylate) microparticles containing carboxyl groups (PGMA-COOH) were coated using highly hydrophilic polymer poly(ethylene glycol) (PEG). PEG was used to reduce nonspecific interactions with proteins and cells while decreasing adhesion of particles to the walls of...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.